Clinical Trial Update: Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of Beta-Glucan and Rituximab in young patients with relapsed or progressive leukemia or lymphoma, including post-transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Post-transplant Lymphoproliferative Disorder

Drugs mentioned

• Beta Glucan (beta-glucan)
• Rituxan (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: TERMINATED